
    
      Eligible patients (patients with glomerular filtration rate < 60 ml/min or high riks patients
      based on Mehran score) that will be undergoing cardiac catheterization/intervention randomly
      assigned to receive allopurinol 300 mg or febuxostat 80 mg 12 hours before and 12 after 1
      exposure of radiocontrast and IV hydration (normal saline 1 ml/kg/hr 12 pre and post
      radiocontrast exposure) or placebo and hydration.

      Exclusion criteria: patients under treatment with allopurinol or febuxostat in the previous
      seven days, known allergy to allopurinol or febuxostat, patients on renal replacement therapy
    
  